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Microwave assisted synthesisAbstract The synthesis of various 3-aryl-furo[3,2-c]coumarins 4a–l has been carried out by
employing two different methodologies under microwave irradiation condition. In the ﬁrst method
different 3-aryl-furo[3,2-c]coumarins 4a–l have been synthesized by reacting various 4-hydroxy cou-
marins 1a–d with appropriate 2-aryl-1-nitro ethenes 2a–c under Nef reaction condition, while in the
second method the same target compounds have been synthesized by reacting various 4-hydroxy
coumarins 1a–d with appropriate aroylmethyl bromides 3a–c under Feist–Benary reaction condi-
tion. All the synthesized compounds were characterized by elemental analysis and IR, 1H NMR,
13C NMR, DEPT-90 spectral analysis. All the synthesized compounds 4a–l were screened for their
antimicrobial activity.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Synthetic organic reactions performed under nontraditional
conditions are gaining popularity, primarily to circumvent
growing environmental concerns (Pillai et al., 2002; Raghven-
dra et al., 2007). Microwave assisted heating is an invaluable
synthesis technology since it offers reduction in reaction time,
improved yields and selectivity. Microwave reaction under sol-
vent free conditions is attractive in offering reduced pollutionwith simplicity in processing and handling (Bejan et al., 2012;
Khabazzadeh et al., 2008).
Coumarin derivatives are widely distributed in nature and
show various biological activities such as Hypoglycaemic,
anti-inﬂammatory, anticancer, antiﬁlarial, antibacterial, anti-
fungal, antiTB etc. (Cristians et al., 2009; Fylaktakidou
et al., 2004; Ghosh et al., 2007; Tripathi et al., 2000; Smyth
et al., 2009; Curir et al., 2007; Xu et al., 2006). Among the het-
erocyclic fused coumarins, furocoumarins form a distinct class
of coumarin derivatives. Many furocoumarins are reported to
have important biological activities such as HIV inhibitory,
vasodialation, anticancer, anti-inﬂuenza, anti-inﬂammatory
(Zhou et al., 2000; Pan et al., 2010; Wang et al., 2004; Yeh
et al., 2010; Kyong-Hwa et al., 2009). Furocoumarins having
furan ring fused to benzene ring of coumarin, have interesting
therapeutic properties like anti-inﬂammatory, anti-inﬂuenza,
anticancer (Bansal et al., 2012; Lacy and O’Kennedy, 2004;
Yeh et al., 2010). Furocoumarins with furan ring fused to
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physiological activities (Lee et al., 2010; Bondock et al.,
2011). Considering the importance of furocoumarins our con-
tinued interest to build-up coumarin based heterocyclic com-
pounds (Brahmbhatt et al., 2011; Patel et al., 2012) led us to
devote our efforts to develop an efﬁcient pathway for the
diversiﬁed synthesis of furo[3,2-c]coumarin derivatives. The
target compounds 4a–l have been synthesized by utilizing
two methodologies, Nef reaction condition (Ballini and Petrin-
i, 2004) (Method A) and Feist–Benary reaction condition (Li,
2009) (Method B) under microwave irradiation.
2. Experimental
Various 4-hydroxy coumarins 1a–d, 2-aryl-1-nitro-ethenes 2a–
c and aroylmethyl bromide 3a–c were prepared using the re-
ported procedure (Papper and Shaha, 1964; Vogel’s text book
of Practical Organic Chemistry, 1996).
General procedure for the synthesis of 3-aryl-furo[3,2-
c]coumarins 4a–l.
2.1. Method A
A solution of appropriate 4-hydroxy coumarin 1a–d (0.002 mol)
and 2-aryl-1-nitro-ethenes 2a–c (0.002 mol) in methanol (5 ml)
containing piperidine in catalytic amount was stirred at room tem-
perature for 10 min and then irradiated for 5–7 min in microwave
at 240 W (40%) power. The residue was treated with water (50 ml)
and then extracted with chloroform (3 · 25 ml). The chloroform
extract was washed with 50% HCl (25 ml), water and dried over
anhydrous sodium sulphate. The removal of chloroform under
vacuumresulted in gummy residue,whichwas subjected to column
chromatography using silica gel and hexane–ethyl acetate (9:1) as
an eluent to afford the compounds 4a–l. The compounds thus ob-
tained were recrystallized from chloroform–hexane.
2.2. Method B
To a solution of appropriate 4-hydroxy coumarin 1a–d
(0.002 mol) and aroylmethyl bromide 3a–c (0.002 mol) in ace-
tic acid (4 ml) ammonium acetate (0.01 mol) was added at
room temperature. The reaction mixture was stirred at room
temperature for 10 min and then irradiated for 2–3 min inTable 1 % yield comparison and reaction time of two methodolog
Compounds. R R1 R2 Reaction tim
Method A
4a H H H 5.5
4b CH3 H H 6.0
4c H CH3 H 5.5
4d Cl H H 5.0
4e H H CH3 5.5
4f CH3 H CH3 6.5
4g H CH3 CH3 6.5
4h Cl H CH3 5.0
4i H H OCH3 6.0
4j CH3 H OCH3 6.5
4k H CH3 OCH3 7.0
4l Cl H OCH3 7.0microwave at 240 W (40%) power. The residue was treated
with water (50 ml) and then extracted with chloroform
(3 · 25 ml). The chloroform extract was washed with 5%
NaHCO3, water and dried over anhydrous sodium sulphate.
The removal of chloroform under vacuum resulted in gummy
residue, which was subjected to column chromatography using
silica gel and hexane–ethyl acetate (9:1) as an eluent to afford
the compounds 4a–l. The compounds thus obtained were
recrystallized from chloroform–hexane Table 1.
2.2.1. 3-Phenyl-4H-furo[3,2-c]coumarin (4a)
IR (KBr, cm1): 3060 (m), 1751 (vs), 1640 (s), 1125 (s); 1H
NMR (400 MHz, CDCl3, d): 7.37–7.59 (m, 6H, C6–H, C7–H,
C8–H, C3
0–H, C40–H and C50–H), 7.78–7.81 (m, 3H, C2–H of
furan ring, C2
0–H and C60–H)), 7.94 (dd, J= 8.0 and 1.2 Hz,
C9–H);
13C NMR (100 MHz, CDCl3, d): 108.53 (C), 112.82
(C), 117.17 (CH), 121.00 (CH), 124.49 (CH), 126.79 (C),
128.39 (C), 128.59 (CH), 128.70 (CH), 129.10 (CH), 130.96
(C), 141.25 (CH), 152.66 (C), 157.84 (C), 158.83 (CO of cou-
marin); Anal. Calcd. for C17H10O3: C, 77.86; H, 3.84%.
Found: C, 77.89; H, 3.96%.
2.2.2. 8-Methyl-3-phenyl-4H-furo[3,2-c]coumarin (4b)
IR (KBr, cm1): 3055 (m), 1740 (vs), 1595 (s), 1110 (s); 1HNMR
(400 MHz, CDCl3, d): 2.49 (s, 3H, CH3), 7.36–7.49 (m, 5H, C6–
H, C7–H, C3
0–H, C40–H and C50–H), 7.71–7.80 (m, 4H, C2–H of
furan ring, C9–H, C2
0–H and C60–H);
13C NMR (100 MHz,
CDCl3, d): 20.99 (CH3), 108.44 (C), 112.48 (C), 116.89 (CH),
120.66 (CH), 126.79 (C), 128.33 (CH), 128.57 (CH), 128.71
(CH), 129.19 (C), 132.03 (CH), 134.34 (C), 141.11 (CH),
150.89 (C), 158.04 (C), 158.89 (CO of coumarin); Anal. Calcd.
for C18H12O3: C, 78.25; H, 4.38%. Found: C, 78.11; H, 4.24%.
2.2.3. 6-Methyl-3-phenyl-4H-furo[3,2-c]coumarin (4c)
IR (KBr, cm1): 3060 (m), 1745 (vs), 1640 (s), 1125 (s); 1H
NMR (400 MHz, CDCl3, d): 2.55 (s, 3H, CH3), 7.26–7.51
(m, 5H, C7–H, C8–H, C3
0–H, C40–H and C50–H), 7.76–7.82
(m, 4H, C2–H of furan ring, C9–H, C2
0–H and C60–H);
13C
NMR (100 MHz, CDCl3, d): 16.09 (CH3), 108.27 (C), 112.50
(C), 118.58 (CH), 124.04 (CH), 126.68 (C), 126.72 (C),
128.30 (CH), 128.56 (CH), 128.66 (CH), 129.24 (C), 132.24
(CH), 141.14 (CH), 151.09 (C), 157.82 (C), 159.28 (CO of cou-ies employed for the synthesis of 4a–l.
e (min.) % Yield M.P. C
Method B Method A Method B
3.0 69 76 178
2.0 67 78 205
2.5 70 78 207
3.0 65 77 185
3.0 69 79 165
2.5 71 81 198
3.5 73 82 186
4.0 75 80 210
3.5 65 74 162
4.0 64 76 160
3.5 68 72 146
4.0 71 77 220
S1102 A.R. Kaneria et al.marin); Anal. Calcd. for C18H12O3: C, 78.25; H, 4.38%.
Found: C, 78.31; H, 4.44%.
2.2.4. 8-Chloro-3-phenyl-4H-furo[3,2-c]coumarin (4d)
IR (KBr, cm1): 3060 (m), 1735 (vs), 1590 (s), 1110 (s); 1H
NMR (400 MHz, CDCl3, d): 7.41–7.52 (m, 5H, C6–H, C7–H,
C3
0–H, C40–H and C50–H), 7.76–7.78 (m, 2H, C20–H and C60–
H), 7.82 (s, 1H, C2–H of furan ring), 7.91 (d, 1H,
J= 2.4 Hz, C9–H proton);
13C NMR (100 MHz, CDCl3, d):
109.23 (C), 113.86 (C), 118.65 (CH), 120.53 (CH), 126.98
(C), 128.56 (CH), 128.63 (CH), 128.70 (CH), 128.75 (C),
130.06 (C), 130.94 (CH), 141.79 (CH), 150.93 (C), 157.23
(C), 157.50 (CO of coumarin); Anal. Calcd. for C17H9ClO3:
C, 68.82; H, 3.06%. Found: C, 68.96; H, 3.22%.
2.2.5. 3-(4-methylphenyl)-4H-furo[3,2-c]coumarin (4e)
IR (KBr, cm1): 3035 (m), 1735 (vs), 1625 (s), 1120 (s); 1H
NMR (400 MHz, CDCl3, d): 2.43 (s, 3H, CH3), 7.30–7.58
(m, 5H, C6–H, C7–H, C8–H, C3
0–H and C50–H), 7.66–7.69
(m, 2H, C2
0–H and C60–H), 7.76 (s, 1H, C2–H of furan ring),
7.93 (dd, 1H, J= 8.0 and 1.2 Hz, C9–H);
13C NMR
(100 MHz, CDCl3, d): 21.31 (CH3), 108.59 (C), 112.86 (C),
117.14 (CH), 120.96 (CH), 124.45 (CH), 126.13 (C), 126.72
(C), 128.58 (CH), 129.29 (CH), 130.87 (CH), 138.29 (C),
140.96 (CH), 152.64 (C), 157.88 (C), 158.71 (CO of coumarin);
Anal. Calcd. for C18H12O3: C, 78.25; H, 4.38%. Found: C,
78.13; H, 4.24%.
2.2.6. 8-Methyl-3-(4-methylphenyl)-4H-furo[3,2-c]coumarin
(4f)
IR (KBr, cm1): 3025 (m), 1735 (vs), 1590 (s), 1105 (s); 1H
NMR (400 MHz, CDCl3, d): 2.42 (s, 3H, CH3), 2.48 (s, 3H,
CH3), 7.27–7.36 (m, 4H, C6–H, C7–H, C3
0–H and C50–H),
7.66–7.73 (m, 4H, C2–H of furan ring, C9–H, C2
0–H and
C6
0–H); 13C NMR (100 MHz, CDCl3, d): 20.98 (CH3),
21.31 (CH3), 108.41 (C), 112.45 (C), 116.80 (CH), 120.60
(CH), 126.20 (C), 126.64 (C), 128.55 (CH), 129.25 (CH),
131.90 (CH), 134.26 (C), 138.19 (C), 140.82 (CH), 150.79
(C), 158.04 (C), 158.72 (CO of coumarin); Anal. Calcd.
for C19H14O3: C, 78.61; H, 4.86%. Found: C, 78.69; H,
4.97%.
2.2.7. 6-Methyl-3-(4-methylphenyl)-4H-furo[3,2-c]coumarin
(4 g)
IR (KBr, cm1): 3120 (m), 1725 (vs), 1630 (s), 1120 (s); 1H
NMR (400 MHz, CDCl3, d): 2.43 (s, 3H, CH3), 2.54 (s, 3H,
CH3), 7.25–7.40 (m, 4H, C7–H, C8–H, C3
0–H, and C50–H),
7.68–7.77 (m, 4H, C2–H of furan ring, C9–H, C2
0–H and
C6
0–H); 13C NMR (100 MHz, CDCl3, d): 16.10 (CH3), 21.31
(CH3), 108.34 (C), 112.55 (C), 118.56 (CH), 124.01 (CH),
126.28 (C), 126.62 (C), 126.69 (C), 128.55 (CH), 129.28
(CH), 132.16 (CH), 138.19 (C), 140.87 (CH), 151.07 (C),
157.88 (C), 159.18 (CO of coumarin); Anal. Calcd. for
C19H14O3: C, 78.61; H, 4.86%. Found: C, 78.51; H, 4.74%.
2.2.8. 8-Chloro-3-(4-methylphenyl)-4H-furo[3,2-c]coumarin
(4h)
IR (KBr, cm1): 3060 (m), 1735 (vs), 1590 (s), 1110 (s); 1H
NMR (400 MHz, CDCl3, d): 2.43 (s, 3H, CH3), 7.28–7.30
(m, 2H, C3
0–H and C50–H), 7.41 (d, 1H, J= 8.8 Hz, C6–H), 7.49 (dd, 1H, J= 8.8 and 2.4 Hz, C7–H), 7.64–7.66 (m,
2H, C2
0–H and C60–H), 7.78 (s, 1H, C2–H of furan ring),
7.89 (d, 1H, J= 2.4 Hz, C9–H);
13C NMR (100 MHz,
CDCl3, d): 21.32 (CH3), 109.24 (C), 113.86 (C), 118.60
(CH), 120.47 (CH), 125.76 (C), 126.88 (C), 128.55 (CH),
129.32 (CH), 130.00 (C), 130.83 (CH), 138.48 (C), 141.51
(CH), 150.88 (C), 157.26 (C), 157.36 (CO of coumarin); Anal.
Calcd. for C18H11ClO3: C, 69.58; H, 3.57%. Found: C, 69.66;
H, 3.69%.
2.2.9. 3-(4-methoxyphenyl)-4H-furo[3,2-c]coumarin (4i)
IR (KBr, cm1): 3045 (m), 1730 (vs), 1595 (s), 1125 (s); 1H
NMR (400 MHz, CDCl3, d): 3.88 (s, 3H, OCH3), 7.00–7.03
(m, 2H, C3
0–H and C50–H), 7.36–7.58 (m, 3H, C6–H, C7–H
and C8–H), 7.71–7.75 (m, 3H, C2–H of furan ring, C2
0–H
and C6
0–H), 7.93 (dd, 1H, J= 8.0 and 1.2 Hz, C9–H);
13C
NMR (100 MHz, CDCl3, d): 55.35 (OCH3), 108.60 (C),
112.92 (C), 114.07 (CH), 117.19 (CH), 121.02 (CH), 121.46
(CH), 124.47 (C), 126.42 (C), 129.96 (CH), 130.86 (CH),
140.60 (CH), 152.64 (C), 158.00 (C), 158.70 (C), 159.79 (CO
of coumarin); Anal. Calcd. for C18H12O4: C, 73.97; H,
4.14%. Found: C, 73.90; H, 4.08%.
2.2.10. 8-Methyl-3-(4-methoxyphenyl)-4H-furo[3,2-
c]coumarin (4j)
IR (KBr, cm1): 3075 (m), 1725 (vs), 1595 (s), 1110 (s); 1H
NMR (400 MHz, CDCl3, d): 2.49 (s, 3H, CH3), 3.88 (s, 3H,
OCH3), 6.99–7.02 (m, 2H, C3
0–H and C50–H), 7.35–7.36 (m,
2H, C6–H and C7–H), 7.70–7.75 (m, 4H, C2–H of furan ring,
C9–H, C2
0–H and C60–H);
13C NMR (100 MHz, CDCl3, d):
20.99 (CH3), 55.34 (OCH3), 108.44 (C), 112.54 (C), 114.03
(CH), 116.87 (CH), 120.65 (CH), 121.55 (C), 126.40 (C),
129.95 (CH), 131.92 (CH), 134.28 (C), 140.45 (CH), 150.84
(C), 158.21 (C), 158.76 (C), 159.74 (CO of coumarin); Anal.
Calcd. for C19H14O4: C, 74.50; H, 4.61%. Found: C, 74.58;
H, 4.73%.
2.2.11. 6-Methyl-3-(4-methoxyphenyl)-4H-furo[3,2-
c]coumarin (4k)
IR (KBr, cm1): 3040 (m), 1730 (vs), 1595 (s), 1120 (s); 1HNMR
(400 MHz, CDCl3, d): 2.55 (s, 3H, CH3), 3.88 (s, 3H, OCH3),
7.00–7.02 (m, 2H, C3
0–H and C50–H), 7.25–7.41 (m, 2H, C7–H
and C8–H), 7.70–7.77 (m, 4H, C2–H of furan ring, C9–H, C2
0–
H and C6
0–H); 13C NMR (100 MHz, CDCl3, d): 16.10 (CH3),
55.35 (OCH3), 108.30 (C), 112.57 (C), 114.03 (CH), 118.57
(CH), 121.62 (C), 124.01 (CH), 126.31 (C), 126.69 (C), 129.92
(CH), 132.15 (CH), 140.48 (CH), 151.05 (C), 158.00 (C),
159.16 (C), 159.73 (CO of coumarin); Anal. Calcd. for
C19H14O4: C, 74.50; H, 4.61%. Found: C, 74.62; H, 4.73%.
2.2.12. 8-Chloro-3-(4-methoxyphenyl)-4H-furo[3,2-c]coumarin
(4l)
IR (KBr, cm1): 3065 (m), 1725 (vs), 1605 (s), 1100 (s); 1H
NMR (400 MHz, CDCl3, d): 3.88 (s, 3H, OCH3), 7.00–7.02
(m, 2H, C3
0–H and C50–H), 7.41 (d, 1H, J= 8.8 Hz, C6–H),
7.49 (dd, 1H, J= 8.8 and 2.4 Hz, C7–H), 7.69–7.72 (m, 2H,
C2
0–H and C60–H), 7.76 (s, 1H, C2–H of furan ring), 7.89 (d,
1H, J= 2.4 Hz, C9–H);
13C NMR (100 MHz, CDCl3, d):
55.34 (OCH3), 109.19 (C), 113.88 (C), 114.07 (CH), 118.59
(CH), 120.47 (CH), 121.06 (C), 126.57 (C), 129.94 (CH),
O O
OH
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Scheme 1 Synthetic scheme for 3-aryl-furo[3,2-c]coumarins 4a–l. (a) Piperidine, Methanol, mw (b) NH4OAc, AcOH, mw.
Table 2 In vitro antimicrobial activity of 3-aryl-furo[3,2-
c]coumarins 3a–l.
Compound Inhibition zone in mm
Bacteria Fungi
E. coli B subtillis C albican
3a 18 11 13
3b 21 14 16
3c 21 12 14
3d 19 10 14
3e 22 12 15
3f 21 11 15
3g 22 10 13
3h 25 10 14
3i 21 09 12
3j 22 09 12
3k 19 10 13
3l 24 11 13
Streptomycin 18 25 NT
Cotrimazole NT NT 20
NT: not tested.
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157.38 (C), 159.87 (CO of coumarin); Anal. Calcd. for
C18H11ClO4: C, 66.17; H, 3.39%. Found: C, 66.05; H, 3.33%.
3. Result and discussion
3.1. Analytical results
A series of 3-aryl-furo[3,2-c]coumarins 4a–l has been synthe-
sized using two methodologies as exempliﬁed in scheme 1.
The structures of all the newly synthesized compounds were
conﬁrmed by elemental analysis and FT-IR, 1H NMR, 13C
NMR, DEPT-90 spectral analysis. Mass spectrum for one rep-
resentative compound 4a was also recorded.
The IR spectra of compounds 4a–l exhibited a strong d-lac-
tone carbonyl (C‚O) stretching band between 1725 and
1751 cm1. C‚C and C–H aromatic stretching band was ob-
served between 1590 and 1640 and 3035 and 3120 cm1,
respectively. The C–O–C stretching of furan moiety was ob-
served between 1100 and 1125 cm1. The 1H NMR spectrum
of compounds 4a–l showed a multiplet between 6.99 and
7.59d for aromatic protons. The C2–H of the furan ring ap-
peared as a singlet at 7.77d. The C20–H and C60–H were ob-
served in downﬁeld region due to close proximity of the
carbonyl group. The C9–H appeared in the most downﬁeld re-
gion due to peri effect of furan ring oxygen. Compounds 4a,
4e, and 4i showed C9
0–H signal as a doublet of doublet around
7.94d (J= 8 and 1.2 Hz) while compounds 4d, 4h, and 4l
showed C9–H signal as a doublet around 7.91d (J= 2.4 Hz).
The 13C NMR spectrum is in good agreement with the struc-
ture assigned. The carbonyl carbon of d-lactone ring of couma-
rin appeared as the most deshielded signal around 158.5d. The
signals appearing between 108 and 157d attributed to aromatic
carbons. The DEPT 90 spectra gave the expected non equiva-
lent tertiary carbon signals. The mass spectrum of selected
compound 4a showed M+ peak at m/z 262 (100%) which is
also the base peak. The appearance of a molecular ion peak
at 262 mass unit supports the structure of compound 4a.
The peaks corresponding to the fragments [M-CO]+, [M-
2(CO)]+, [M-2(CO)-H]+ and [M-3(CO)]+ were observed at
m/z 234 (5%), 206 (30%), 205 (12%) and 176 (35%), respec-
tively. The other fragments [C7H4]
+, [C6H5]
+ and [C4H3]
+
showed peaks at 88 (27%), 77 (8%) and 51 (10%), respectively.3.2. Antimicrobial activity
All the synthesized compounds 3a–l were screened for their
antimicrobial activities using Streptomycin and Cotrimazole
as standard drugs. Compounds 3a–l were screened against
Escherichia coli (MTCC 443) (Gram-negative bacteria) and
Bacillus subtilis (MTCC 441) (Gram-positive bacteria) and
antifungal activity against Candida albican (MTCC 227) (Fun-
gi). The evaluation of antimicrobial activity was carried out
using the agar cup diffusion method. The results are summa-
rized in Table 2.
The antimicrobial activity data revealed that almost all the
compounds 4a–l exhibited promising antibacterial activity
against gram negative bacteria E. coli compared to streptomy-
cin. Compound 4h showed the highest antibacterial effective-
ness against gram negative bacteria E. coli. Compounds 4b,
4c, 4e–g, 4i, 4j and 4l were found to exhibit better activity com-
pared to streptomycin against E. coli. Compounds 4a, 4d and
4k showed comparable activity to streptomycin against gram
S1104 A.R. Kaneria et al.negative bacterial strain. None of the compounds showed bet-
ter activity against gram positive bacterial strain Bacillus sub-
tilis and fungi Candida albicans.
A close look at the SAR (structure activity relationship) of
these compounds clearly bares the inherent antimicrobial
activity associated with the basic skeleton consisting of furo
fused coumarin and the phenyl ring as seen in the case of the
unsubstituted compound 4a with zone of inhibition similar
to that of standard streptomycin, which in some cases was en-
hanced by the inﬂuence of some substituents and decreased by
some other substituents. Compounds 4a–d having unsubstitut-
ed phenyl ring do not affect the antimicrobial activity to a lar-
ger extent. An increase in antibacterial activity was observed
when the phenyl ring was substituted at para positions by
the electron releasing group such as CH3 and OCH3 as seen
in the case of 4e and 4i. Introduction of another electron
releasing group does not affect the activity as seen in the case
of compounds 4f, 4g, 4j and 4k. Among the compounds 4a–l,
the compounds 4h and 4l (R = Cl) showed excellent antibac-
terial activity against gram negative bacteria E. coli. None of
the compounds showed promising activity against Bacillus sub-
tilis and Candida albicans.
4. Conclusion
In conclusion, simple and convenient microwave assisted meth-
ods have been developed for the synthesis of 3-aryl-furo[3,2-
c]coumarin derivatives 4a–l utilizing the Nef reaction condition
(Method A) and Feist–Benary reaction condition (Method B)
whichmay be further useful to synthesize other medicinally use-
ful furanocoumarins. However Method B is superior from the
view of the yield and reaction time compared with Method A.Acknowledgements
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